Investment Q&A

Q: In your reply to Indra you have a compelling buy price for Thomson Reuters of $150. It's at $221 now - you conceivably see a 32% decline before it gets compelling to buy? That's quite a drop.

Q: Hi Peter and the 5i Team,

PBH continues to be a very frustrating stock which we bought for a RRIF and a TFSA. Even though 5i rates it as a “B” and most analysts rate it highly, for those of us who purchased it when it was trading at much loftier levels, what is it going to take for at least a break-even position?

In the case of the RRIF, PBH was purchased for 96.24 per share. It closed on January 9 with a price of $79.26. When dividends are included, our loss is still $3900.

National Bank rates PBH as “sector perform” with a target price of $99.00. On the 5i website, the stock is trading in a range of $75.67 (year low) and $97.10 (year high). Even with all the positive news surrounding PBH (acquisitions, etc.), the stock is retreating to only $3.59 above its year low.

I read recently that beef prices are at an all-time high. The CBC had a story called “Beef prices hit record high at the grocery store — and on the ranch, too”. Is this somehow holding back PBH?

Is PBH a stock worth holding? Are there any tailwinds on the horizon that could lift PBH out of the doldrums?

Thanks as always for helping me to make informed decisions.

Q: Would you consider KLA and/or ASML as "core" IT/AI holdings for 3-5 years, apart from current M 7 holdings. Among IT/AI opportunities available, how would you rank one or both, given current valuations, and taking into account vulnerabilities [China]. Or, would you suggest 3 others instead.
Thanks

Q: What are your thoughts on this company?Do you consider it a buy given it's dramatic drop in price over the past year or do you think there is more downside to come?

Q: Outlook for this name?

Q: Share price of LLY is down again this morning (January 14) after the company reported results below analysts’ expectations. For the longer term the company’s forward guidance (just-issued) is slightly above expectations. What do you have as PEG please? Given the firm's latest results and fwd guidance, what would you say is a reasonable price range to buy at :
(1) for a longer-term hold ; and
(2) what would be reasonable price range for a parent aged 75 whose portfolios is tilted towards high growth companies— or would you avoid LLY in the latter case? :ao:sab

Q: Is there a total return ETF similar to HXS, but for the total US market? If not, are there any corporate funds you’d recommend to do the same thing?

Thanks.

Q: I have owned CVD for a while and while it has shown decent results, I am in the unfortunate position of being unsure why I bought it! If I understand the product, a series of bonds (duration unknown to me) would rise faster than a similar bond fund without the conversion features if equity markets rose. I, therefore, assume that in declining equity markets, the fund would decrease less than the underlying equities because the bond provides a "floor" to some extent.

When the conversion price is reached does the fund buy the equity and keep it or does it sell it on the market and use the proceeds to buy more bonds?

If my understanding is correct would you not be better off buying pure equities if you expect the markets to rise and a pure bond bond if you think markets are going to decline? So I am left with the question: "What is the value proposition of a convertible bond fund?"

Appreciate your insight.

Paul F.

Q: I have another question on these covered call style funds. If the underlying stock rises and the 'at the money' option is exercised and the stock is sold, do the funds have to rebuy equivalent stock?

Or is part of the risk profile that they may be paying out some of the increase in NAV as monthly dividends and the NAV will then decrease over time (or at least the # of shares will decrease).

Q: considering a buy
i am looking for defensive but with potential for growth
i like the pharmacy/food stores they are rolling out
please advise on this buy and please suggest another 2 options in list of defensive stocks
i am generally diversified and hold financials and tech
many thanks

Q: Can I get a valuation/ outlook on this name

Q: Hi 5i,

Can i have your opinion on CRNT?

I was conaidering a small position in a bag of small caps but i see no news on the 8% drop.

Thanks

Q: Hi 5i,

Advice please - I am down almost 50% with MG; it accounts for 7% in a LIRA account. Do I hold faith it will rebound at some point or cut my losses? Cannot touch LIRA for another 15yrs. Thank you!

Q: For your Growth and Balanced Equity Portfolios, what would the current "Sector" allocations look like and how significant is this factor in selecting your positions?
Thanks, Brian

Q: Hi,

Do you have a view as to how the TSX will respond if and when Trump announces 25% tariffs on Canadian goods?

Will oil and gas sector take a hit, like Suncor, and CNQ?

Thanks

Robert

Q: Can you give suggestions for your three best Canadian and us quality value, largecap stocks ?
Similarly your three best Canadian and US quality growth large cap stocks?
Pls give a compelling entry point and rank best first
Appreciate all your advice

Q: If you were considering defensive choices in the current climate for a retired client relying on an income portfolio of securities for a large percentage of their income, would you consider VVR? If not, what sort of defensive income-producing diversifier would you prefer?

Q: Hello 5i
One of the advantages a small investor may have is access to buying small companies where Institutional Investors would not be able to buy a meaningful position. Easy to say that Source Rock Royalties is a tiny company at $40 MM.

As they have been operating since 2013 (public since March 2022) with a successful dividend + Growth Model and never a negative cashflow quarter, would you consider this one a decent play for Royalty Income. The Dividend yield is high (9%) with low payout ratio (60%) and cash on the books ...... so it appears the business and income stream are sustainable.

With a quick review of their financials and business model, do you see anything that would be of concern for an investor looking to take up a position to enhance Portfolio income?

I did notice the prior two Q&A.
Thanks

Q: I am wondering about the exposure of the following natural resource stocks to tariffs. Would you consider selling any?

Q: Good morning. May we have your assessment of AYA as to why it has tanked in the past 3 months, what your prognosis is for it, and what your buy-in price would be? Grazzia